Helicobacter Pylori Non-Invasive Testing Market
Rising government funding and research initiatives are setting the stage for non-invasive testing for Helicobacter pylori
Helicobacter Pylori Non-Invasive Testing Market by Non-invasive Test Type, Test, End User & Region - Forecast 2022 - 2033
Helicobacter Pylori Non-Invasive Testing Market Outlook 2022 - 2033
The global helicobacter pylori non-invasive testing market is projected to register at a moderate-paced CAGR of 4.4% over the forecast period. The helicobacter pylori non-invasive testing market is currently valued at US$ 650.50 Mn in 2023. By 2033, demand for helicobacter pylori non-invasive testing is expected to reach a high of US$ 1000.57 Mn.
This growth in the adoption of helicobacter pylori non-invasive testing is supported by the following:
- Non-invasive testing has become increasingly popular for identifying H. pylori infections.
- The dearth of endoscopic resources
- Infection awareness among governments is growing, which is important for getting a proper diagnosis.
- A dramatic increase in the need for point-of-care testing devices
- The accessibility of diagnostic tools.
Let us know your requirement to get
100% FREE customization
Immunoassay Market’s Projected Growth in the Upcoming Years
Immunoassays are biochemical tests that determine how much of an analyte is present. It doesn't matter what size the analyte is; it might be a huge protein, an antibody the body has created in response to an illness, or a little molecule. The accuracy and reliability of immunoassays are unparalleled. They are very specific since antibodies and purified antigens are used as reagents. Diseases can be diagnosed more precisely using this assay since it measures antigen presence. It is a highly selective bioanalytical approach that uses an antibody or antigen as a biorecognition agent to quantify the presence or quantity of analytes ranging from tiny molecules to macromolecules in solution.
Due to the presence of several advanced technologies, such as the enzyme immunoassays, which are used for the detection of antibodies, the immunoassay segment currently holds a significant market share in the helicobacter pylori non-invasive testing market and is expected to show a similar trend over the forecast period. Key factors propelling the immunoassay market are the growing incidence of gastritis and infections caused by Helicobacter pylori, as well as technical developments.
For instance, in 2021, the worldwide prevalence of gastritis was estimated to be between 50.0% and 56.0%, according to a study titled "Diagnosis of Helicobacter pylori Infection and Recent Advances," with the prevalence of chronic atrophic gastritis falling within that range between 20% and 30%. Helicobacter pylori infection was shown to be proportional to gastritis prevalence, and cases of Helicobacter pylori-positive gastritis were found to account for more than 80.0% of all cases. Since such illnesses are typically detected by immunoassays, rising instances of Helicobacter pylori infection and gastritis are expected to drive the segment growth throughout the forecast period.
|
Market Value (2023) |
US$ 650.50 Mn |
|
Market Value (2033) |
US$ 1000.57 Mn |
|
CAGR |
4.4% |
Comparative Analysis of Adjacent Markets
Helicobacter Pylori Non-Invasive Testing Market:
|
Differentiating Aspects |
Helicobacter Pylori Non-Invasive Testing Market |
|
CAGR |
4.4% |
|
Market Valuation in 2023 |
US$ 650.50 Mn |
|
Projected Market Value in 2033 |
US$ 1000.57 Mn |
|
Drivers |
|
Non-invasive Ventilators Market:
|
Differentiating Aspects |
Non-invasive Ventilators Market |
|
CAGR |
5.9% |
|
Market Valuation in 2023 |
US$ 2.2 Bn |
|
Projected Market Value in 2033 |
US$ 3.9 Bn |
|
Drivers |
|
Serological Testing Market:
|
Differentiating Aspects |
Serological Testing Market |
|
CAGR |
16.1% |
|
Market Valuation in 2023 |
US$ 191.4 Mn |
|
Projected Market Value in 2033 |
US$ 813.6 Mn |
|
Drivers |
|
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystKey Drivers and Restraints for the Helicobacter Pylori Non-Invasive Testing Market
Increased Patient Requirement for POC Increases the Demand for H. pylori Tests Drives the Development of the Industry as a Whole
The National Institutes of Health (NIH) research states that IgG serology, the C-Urea Breath Test (UBT), and the monoclonal stool antigen test are all non-invasive, Point-of-care (POC) diagnostic options for primary care settings that can detect H. pylori. UBT is the only one of these that reliably verifies whether an infection is present or has been eradicated. According to the research published in Gut and Liver, UBT is an accurate, non-invasive option that is safe for use on both children and pregnant women.
In addition, H. pylori laboratory test results can now be obtained in a shorter amount of time owing to Point-of-care Testing (POCT), a tried-and-true method. Popularity, the number of people getting tested, and the variety of therapeutic uses for POCTs have all increased as leading companies keep releasing new models. In addition, Point-of-care Testing (POCT) is now widely used in all hospitals and is increasingly being adopted as the norm in other types of healthcare facilities. The global helicobacter pylori non-invasive testing market is expected to expand because of the aforementioned factors throughout the forecast period. This means that the increasing number of H. pylori sufferers is a key factor propelling the helicobacter pylori non-invasive testing market forward.
Industry's growth may be hampered by a lack of educated doctors to perform intrusive tests.
To accurately diagnose Helicobacter pylori infection and determine the best course of therapy, a surgeon or medical professional must perform an invasive procedure that often includes a biopsy and endoscopy. Market growth could be stymied, however, if countries with fewer healthcare resources and a corresponding shortage of trained professionals saw a decline in the number of people getting their diseases checked out. Unfortunately, many nations with a low or middle income lack the hospital and medical training infrastructure necessary to produce highly qualified physicians. However, there are additional difficulties for doctors when treating Helicobacter pylori, as no first-line therapy is effective for everyone.
The helicobacter pylori non-invasive testing market is expected to expand at a modest rate worldwide. Although testing has become more common, diagnosis has been hindered by the fact that HIV infection often has no outward symptoms. This is a major factor in the market's slow expansion. It is also expected that h. pylori non-invasive testing is expected to decrease as attention is redirected to ending the current coronavirus pandemic.
Category-wise Insights
From 2023 to 2033, the clinic market is expected to grow at a CAGR of over 6%, as more people choose clinics over hospitals because of their lower costs and higher quality of care. The reason for this is that people are more likely to seek help from clinics since they offer high-quality care and respond quickly to patient needs, resulting in effective treatment at an affordable price. The premium services provided by clinics as a result of efficient disease management tactics are also expected to fuel market growth.
Due to its non-invasive nature and its ability to offer speedy findings, the POC testing segment accounted for more than 35% of business. This is due, in large part, to rising R&D spending and joint research activities amongst industry heavyweights that are fostering innovation and new product development.
The helicobacter pylori non-invasive testing market may be broken down into two distinct subsegments: invasive helicobacter pylori tests and non-invasive helicobacter pylori tests. Since quick urease tests are both effective and inexpensive, this market subsegment is expected to grow at a CAGR of 6.5% between 2023 and 2032. Patients who do not respond well to antibiotic medication, who have symptoms of severe gastrointestinal issues, and who require gastric endoscopy have a significant demand for invasive diagnostic methods.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Regional Insights
How is the US Helicobacter Pylori Non-Invasive Testing Market Developing?
Globally, North America accounts for the largest helicobacter pylori non-invasive testing market. The expansion of healthcare infrastructure in addition to the rising incidence of stomach cancer, duodenal ulcers, and gastric ulcers in North America are driving forces behind the helicobacter pylori non-invasive testing market's expansion.
The NIH found that 5 percent of U.S. youngsters under the age of 10 have H. pylori in their systems. In addition, 30%-40% of Americans have H. pylori infection, according to research from the US Department of Health and Human Services. Furthermore, socioeconomic variables such as poor income, less education, home crowding, and immigration all contribute to a higher prevalence of H. pylori infection in the US's Hispanic and Black populations. In order to treat H. pylori, the FDA recommends either Proton Pump Inhibitors (PPI) and two antibiotics or bismuth subsalicylate, acid suppressors, and two antibiotics, as detailed in a paper available from the ClinMed International Library.
There is resistance to effectiveness with the currently available first-line medication regimens. Due to resistance in H. pylori to common antibiotics, the United States, for example, observed 75% eradication rates utilising these regimens. The largest rates of resistance are shown with "Clarithromycin" and "Metronidazole," and characteristics related with resistance include race, age, location, and the presence or absence of ulcer disease.
What are the driving factors for the Chinese Helicobacter Pylori Non-Invasive Testing Market?
The market for non-invasive testing for Helicobacter Pylori (H. pylori) in Asia and the Pacific is dominated by China. When it comes to healthcare and pharmaceuticals, China is a developing powerhouse in the Asia-Pacific region. Many international manufacturers of medical, pharmaceutical, and biotechnology products are based in China. High rates of H. pylori infection and gastric (stomach) cancer cases have spurred the development of diagnostic testing kits and technologies for H. pylori detection by pharmaceutical and biotechnology firms.
What are the defining characteristics of the Japanese Helicobacter Pylori Non-Invasive Testing Market?
The Japanese medical industry is among the world's most advanced market. Due to widespread infection with H. pylori and a penchant for consuming smoked and salted foods, Roswell Park Comprehensive Cancer Center reports that Japan has an alarmingly high incidence of stomach cancer. In Japan, 50,000 individuals each year are killed by stomach cancer, making it the third deadliest form of the disease. In addition, 98% of gastric cancer in Japan can be attributed to H. pylori, according to a study published in 2020 in Wiley Online Library.
Recent investigations have indicated that H. pylori infection is the primary cause of stomach cancer, while it is one of many factors. The expansion of the helicobacter pylori non-invasive testing market in Japan is anticipated to benefit from the aforementioned factors over the forecast period.
Competitive Landscape
Companies like DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. are all major players in the global helicobacter pylori maerket. These leaders are anticipated to retain their positions of prominence during the prediction horizon.
Some recent developments in the helicobacter pylori non-invasive testing market include:
Meridian Bioscience, Inc. announced in March 2020 that its novel Curian and Curian HpSA assay had been approved by the Food and Drug Administration. They hope that their efforts to preserve their position as the industry leader in testing for gastrointestinal diseases would be aided by the introduction of this analyzer and its initial assay.
Thermo Fischer Scientific announced in December 2021 that it would be purchasing PPD, Inc. for US$17.4 billion. PPD is a top global provider of clinical research services to the biopharma & biotech industry.
Key Segments in the Helicobacter Pylori Non-Invasive Testing Market
By Non-invasive Test Type:
- Serology Test
- Stool Antigen Test
- Urea Breath Test
By Test Type:
- Laboratory-based Tests
- Point-of-Care Tests
By End-user:
- Hospitals
- Diagnostic Labs
- Clinics
By Region:
- North America
- Latin America
- Asia Pacific
- MEA (Middle East and Africa)
- Europe
Frequently Asked Questions
The growth outlook for the Helicobacter Pylori Non-Invasive Testing market is predicted to advance at a CAGR of 4.4% from 2023-to 2033.
Europe region is anticipated to lead the Helicobacter Pylori Non-Invasive Testing market over the forecast period.
The valuation of the Helicobacter Pylori Non-Invasive Testing market stands at US$ 650.50 Mn in 2023.
The Helicobacter Pylori Non-Invasive Testing market is likely to hold a valuation of US$ 1000.57 Mn by 2033.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032
5.3.1. Serology Test
5.3.2. Stool Antigen Test (SAT)
5.3.3. Urea Breath Test (UBT)
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Test Method
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Test Method, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Method, 2022-2032
6.3.1. Laboratory-based Tests
6.3.2. Point-of-Care Tests
6.4. Y-o-Y Growth Trend Analysis By Test Method, 2017-2021
6.5. Absolute $ Opportunity Analysis By Test Method, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-user
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End-user , 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user , 2022-2032
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Diagnostic Laboratories
7.4. Y-o-Y Growth Trend Analysis By End-user , 2017-2021
7.5. Absolute $ Opportunity Analysis By End-user , 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Test Type
9.2.3. By Test Method
9.2.4. By End-user
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.3.3. By Test Method
9.3.4. By End-user
9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Test Type
10.2.3. By Test Method
10.2.4. By End-user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By Test Method
10.3.4. By End-user
10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Test Type
11.2.3. By Test Method
11.2.4. By End-user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.3.3. By Test Method
11.3.4. By End-user
11.4. Key Takeaways
12. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Test Type
12.2.3. By Test Method
12.2.4. By End-user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test Type
12.3.3. By Test Method
12.3.4. By End-user
12.4. Key Takeaways
13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Test Type
13.2.3. By Test Method
13.2.4. By End-user
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Test Type
13.3.3. By Test Method
13.3.4. By End-user
13.4. Key Takeaways
14. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Test Type
14.2.3. By Test Method
14.2.4. By End-user
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Test Type
14.3.3. By Test Method
14.3.4. By End-user
14.4. Key Takeaways
15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Test Type
15.2.3. By Test Method
15.2.4. By End-user
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Test Type
15.3.3. By Test Method
15.3.4. By End-user
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Test Type
16.1.2.2. By Test Method
16.1.2.3. By End-user
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Test Type
16.2.2.2. By Test Method
16.2.2.3. By End-user
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Test Type
16.3.2.2. By Test Method
16.3.2.3. By End-user
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Test Type
16.4.2.2. By Test Method
16.4.2.3. By End-user
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Test Type
16.5.2.2. By Test Method
16.5.2.3. By End-user
16.6. U.K.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Test Type
16.6.2.2. By Test Method
16.6.2.3. By End-user
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Test Type
16.7.2.2. By Test Method
16.7.2.3. By End-user
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Test Type
16.8.2.2. By Test Method
16.8.2.3. By End-user
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Test Type
16.9.2.2. By Test Method
16.9.2.3. By End-user
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Test Type
16.10.2.2. By Test Method
16.10.2.3. By End-user
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Test Type
16.11.2.2. By Test Method
16.11.2.3. By End-user
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Test Type
16.12.2.2. By Test Method
16.12.2.3. By End-user
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Test Type
16.13.2.2. By Test Method
16.13.2.3. By End-user
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Test Type
16.14.2.2. By Test Method
16.14.2.3. By End-user
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Test Type
16.15.2.2. By Test Method
16.15.2.3. By End-user
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Test Type
16.16.2.2. By Test Method
16.16.2.3. By End-user
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Test Type
16.17.2.2. By Test Method
16.17.2.3. By End-user
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Test Type
16.18.2.2. By Test Method
16.18.2.3. By End-user
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Test Type
16.19.2.2. By Test Method
16.19.2.3. By End-user
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Test Type
16.20.2.2. By Test Method
16.20.2.3. By End-user
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Test Type
16.21.2.2. By Test Method
16.21.2.3. By End-user
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Test Type
17.3.3. By Test Method
17.3.4. By End-user
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. DiaSorin S.p.A.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Meridian Bioscience, Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Exalenz Bioscience Ltd.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Alere
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Thermo Fisher Scientific
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Biomerica, Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Certest Biotec S.L.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Sekisui Diagnostics
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. CorisBioconcept SPRL
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 3: Global Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 4: Global Market Value (US$ Mn) Forecast by End-user , 2017-2032
Table 5: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: North America Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 7: North America Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 8: North America Market Value (US$ Mn) Forecast by End-user , 2017-2032
Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 12: Latin America Market Value (US$ Mn) Forecast by End-user , 2017-2032
Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 15: Europe Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 16: Europe Market Value (US$ Mn) Forecast by End-user , 2017-2032
Table 17: South Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: South Asia Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 19: South Asia Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 20: South Asia Market Value (US$ Mn) Forecast by End-user , 2017-2032
Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: East Asia Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 23: East Asia Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 24: East Asia Market Value (US$ Mn) Forecast by End-user , 2017-2032
Table 25: Oceania Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: Oceania Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 27: Oceania Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 28: Oceania Market Value (US$ Mn) Forecast by End-user , 2017-2032
Table 29: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 30: MEA Market Value (US$ Mn) Forecast by Test Type, 2017-2032
Table 31: MEA Market Value (US$ Mn) Forecast by Test Method, 2017-2032
Table 32: MEA Market Value (US$ Mn) Forecast by End-user , 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Test Type, 2022-2032
Figure 2: Global Market Value (US$ Mn) by Test Method, 2022-2032
Figure 3: Global Market Value (US$ Mn) by End-user , 2022-2032
Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 9: Global Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 11: Global Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 14: Global Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 17: Global Market Attractiveness by Test Type, 2022-2032
Figure 18: Global Market Attractiveness by Test Method, 2022-2032
Figure 19: Global Market Attractiveness by End-user , 2022-2032
Figure 20: Global Market Attractiveness by Region, 2022-2032
Figure 21: North America Market Value (US$ Mn) by Test Type, 2022-2032
Figure 22: North America Market Value (US$ Mn) by Test Method, 2022-2032
Figure 23: North America Market Value (US$ Mn) by End-user , 2022-2032
Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 31: North America Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 34: North America Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 37: North America Market Attractiveness by Test Type, 2022-2032
Figure 38: North America Market Attractiveness by Test Method, 2022-2032
Figure 39: North America Market Attractiveness by End-user , 2022-2032
Figure 40: North America Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Market Value (US$ Mn) by Test Type, 2022-2032
Figure 42: Latin America Market Value (US$ Mn) by Test Method, 2022-2032
Figure 43: Latin America Market Value (US$ Mn) by End-user , 2022-2032
Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 51: Latin America Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 54: Latin America Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 57: Latin America Market Attractiveness by Test Type, 2022-2032
Figure 58: Latin America Market Attractiveness by Test Method, 2022-2032
Figure 59: Latin America Market Attractiveness by End-user , 2022-2032
Figure 60: Latin America Market Attractiveness by Country, 2022-2032
Figure 61: Europe Market Value (US$ Mn) by Test Type, 2022-2032
Figure 62: Europe Market Value (US$ Mn) by Test Method, 2022-2032
Figure 63: Europe Market Value (US$ Mn) by End-user , 2022-2032
Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 71: Europe Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 74: Europe Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 77: Europe Market Attractiveness by Test Type, 2022-2032
Figure 78: Europe Market Attractiveness by Test Method, 2022-2032
Figure 79: Europe Market Attractiveness by End-user , 2022-2032
Figure 80: Europe Market Attractiveness by Country, 2022-2032
Figure 81: South Asia Market Value (US$ Mn) by Test Type, 2022-2032
Figure 82: South Asia Market Value (US$ Mn) by Test Method, 2022-2032
Figure 83: South Asia Market Value (US$ Mn) by End-user , 2022-2032
Figure 84: South Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 85: South Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: South Asia Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 89: South Asia Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 91: South Asia Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 92: South Asia Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 94: South Asia Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 95: South Asia Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 97: South Asia Market Attractiveness by Test Type, 2022-2032
Figure 98: South Asia Market Attractiveness by Test Method, 2022-2032
Figure 99: South Asia Market Attractiveness by End-user , 2022-2032
Figure 100: South Asia Market Attractiveness by Country, 2022-2032
Figure 101: East Asia Market Value (US$ Mn) by Test Type, 2022-2032
Figure 102: East Asia Market Value (US$ Mn) by Test Method, 2022-2032
Figure 103: East Asia Market Value (US$ Mn) by End-user , 2022-2032
Figure 104: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 105: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: East Asia Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 109: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 111: East Asia Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 112: East Asia Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 114: East Asia Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 115: East Asia Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 117: East Asia Market Attractiveness by Test Type, 2022-2032
Figure 118: East Asia Market Attractiveness by Test Method, 2022-2032
Figure 119: East Asia Market Attractiveness by End-user , 2022-2032
Figure 120: East Asia Market Attractiveness by Country, 2022-2032
Figure 121: Oceania Market Value (US$ Mn) by Test Type, 2022-2032
Figure 122: Oceania Market Value (US$ Mn) by Test Method, 2022-2032
Figure 123: Oceania Market Value (US$ Mn) by End-user , 2022-2032
Figure 124: Oceania Market Value (US$ Mn) by Country, 2022-2032
Figure 125: Oceania Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: Oceania Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 129: Oceania Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 131: Oceania Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 132: Oceania Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 134: Oceania Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 135: Oceania Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 137: Oceania Market Attractiveness by Test Type, 2022-2032
Figure 138: Oceania Market Attractiveness by Test Method, 2022-2032
Figure 139: Oceania Market Attractiveness by End-user , 2022-2032
Figure 140: Oceania Market Attractiveness by Country, 2022-2032
Figure 141: MEA Market Value (US$ Mn) by Test Type, 2022-2032
Figure 142: MEA Market Value (US$ Mn) by Test Method, 2022-2032
Figure 143: MEA Market Value (US$ Mn) by End-user , 2022-2032
Figure 144: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 145: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 148: MEA Market Value (US$ Mn) Analysis by Test Type, 2017-2032
Figure 149: MEA Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 150: MEA Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 151: MEA Market Value (US$ Mn) Analysis by Test Method, 2017-2032
Figure 152: MEA Market Value Share (%) and BPS Analysis by Test Method, 2022-2032
Figure 153: MEA Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032
Figure 154: MEA Market Value (US$ Mn) Analysis by End-user , 2017-2032
Figure 155: MEA Market Value Share (%) and BPS Analysis by End-user , 2022-2032
Figure 156: MEA Market Y-o-Y Growth (%) Projections by End-user , 2022-2032
Figure 157: MEA Market Attractiveness by Test Type, 2022-2032
Figure 158: MEA Market Attractiveness by Test Method, 2022-2032
Figure 159: MEA Market Attractiveness by End-user , 2022-2032
Figure 160: MEA Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
